Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
HEALTH
Biotech Movers: Luminex, Exelixis, AMAG Pharmaceuticals
By Armie Margaret Lee
May 2, 2017 9:19 AM EDT
PRESS RELEASES
Luminex Corporation To Present At 39th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Dec 16, 2020 2:23 PM EST
PRESS RELEASES
Luminex Corporation Declares Fourth Quarter Cash Dividend
By PR Newswire
Dec 7, 2020 10:59 AM EST
PRESS RELEASES
Luminex Receives BARDA Award To Support 510(k) Filing For NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2
By PR Newswire
Sep 24, 2020 4:05 PM EDT
PRESS RELEASES
Luminex Receives BARDA Award To Support Enhancement Of COVID-19 Multiplex Antibody Test
By PR Newswire
Sep 23, 2020 4:05 PM EDT
PRESS RELEASES
Luminex Corporation Declares Third Quarter Cash Dividend
By PR Newswire
Sep 15, 2020 7:30 AM EDT
PRESS RELEASES
Luminex Corporation Announces Departure Of G. Walter Loewenbaum From Its Board Of Directors
By PR Newswire
Aug 4, 2020 4:15 PM EDT
PRESS RELEASES
Luminex Files For Emergency Use Authorization For Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2
By PR Newswire
Jul 22, 2020 5:00 AM EDT
PRESS RELEASES
Luminex Corporation Second Quarter Earnings Release Rescheduled For August 4, 2020
By PR Newswire
Jul 20, 2020 1:16 PM EDT
PRESS RELEASES
Luminex Receives FDA Emergency Use Authorization For COVID-19 Antibody Test
By PR Newswire
Jul 20, 2020 5:00 AM EDT
PRESS RELEASES
Luminex Corporation Pre-Release Of 2nd Quarter 2020 Revenue
By PR Newswire
Jul 8, 2020 9:46 AM EDT
PRESS RELEASES
Luminex Corporation Pre-Release Of 2nd Quarter 2020 Revenue
By PR Newswire
Jul 8, 2020 7:00 AM EDT
PRESS RELEASES
Luminex Submits Emergency Use Authorization Request To U.S. FDA For COVID-19 Antibody Test
By PR Newswire
Jun 29, 2020 4:01 PM EDT
PRESS RELEASES
Luminex Corporation Declares Second Quarter Cash Dividend
By PR Newswire
May 22, 2020 7:00 AM EDT
PRESS RELEASES
Luminex Corporation First Quarter Earnings Release Rescheduled For May 4, 2020
By PR Newswire
Apr 22, 2020 8:30 AM EDT
PRESS RELEASES
Luminex Corporation Pre-Release Of 1st Quarter Revenue
By PR Newswire
Apr 6, 2020 4:30 PM EDT
PRESS RELEASES
Luminex Receives FDA Emergency Use Authorization For ARIES® SARS-CoV-2 Assay To Detect Virus Responsible For COVID-19 Disease
By PR Newswire
Apr 6, 2020 7:30 AM EDT
PRESS RELEASES
Luminex Receives FDA Emergency Use Authorization For NxTAG® CoV Extended Panel To Detect The SARS-CoV-2 Virus That Causes COVID-19 Disease
By PR Newswire
Mar 27, 2020 4:05 PM EDT
PRESS RELEASES
Luminex Provides Update On SARS-CoV-2 Validation Testing Efforts
By PR Newswire
Mar 13, 2020 7:30 AM EDT
PRESS RELEASES
Luminex Provides Updates On Critical Efforts Related To Novel Coronavirus
By PR Newswire
Mar 4, 2020 7:30 AM EST
PRESS RELEASES
Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay For FDA Clearance
By PR Newswire
Feb 24, 2020 9:00 AM EST
PRESS RELEASES
Luminex Corporation Declares First Quarter Cash Dividend
By PR Newswire
Feb 18, 2020 11:57 AM EST
PRESS RELEASES
Luminex Corporation To Participate At Upcoming Healthcare Investor Conferences In March 2020
By PR Newswire
Feb 13, 2020 3:10 PM EST
PRESS RELEASES
Luminex Corporation To Release Fourth Quarter And Full-Year 2019 Results After Market Close On February 10, 2020
By PR Newswire
Jan 23, 2020 9:02 AM EST
PRESS RELEASES
Luminex Corporation Announces 2019 Highlights And 2020 Guidance; Company To Present At 38th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Jan 12, 2020 5:00 PM EST